SEP
OGN icon

Signature Equity Partners’s Organon & Co OGN Stock Holding History

Signature Equity Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122 Sell
9
-15
-63% -$179 ﹤0.01% 1559
2026
Q1 		$144 Buy
24
+6
+33% +$45 ﹤0.01% 1509
2025
Q4 		$129 Buy
+18
New +$142 ﹤0.01% 1666

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Signature Equity Partners's OGN Position: Q2 2026 in Review

Signature Equity Partners reduced its Organon & Co (OGN) stake by 63% in Q2 2026, selling an estimated $179 and leaving 9 shares worth $122. The position accounts for ﹤0.01% of the portfolio, ranked #1559.

Signature Equity Partners first reported a position in OGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $144 in Q1 2026. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Signature Equity Partners held 9 shares of Organon & Co worth $122 as of Q2 2026.
  • Signature Equity Partners sold 15 Organon & Co shares in Q2 2026, an estimated $179.
  • Organon & Co made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #1559 holding.
  • Signature Equity Partners first reported a position in Organon & Co in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Organon & Co position peaked at $144 in Q1 2026.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.